srch

Recent News & Activity. There was an issue with loading news and activities.

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures. Its novel and patented, rapidly dissolving sublingual tablet, provides a needle and opioid-free solution for patients and caregivers.

NeuroBo is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies. Boston, Massachusetts, United ...

Boston Pharmaceuticals is a biotechnology company.

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for our diverse pipeline.

Boston Pharmaceuticals leverages a highly experienced drug development team to generate clinical data to create value for their organization and their partners. They have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for their diverse pipeline.

Contacts ; Craig Basson. Chief Medical Officer ; Ian Sanderson. CFO ; Ian Sanderson.

Boston Pharmaceuticals leverages a highly experienced drug development team to generate clinical data to create value for their organization and their ...

Industries. Pharmaceutical · Headquarters Regions Greater Boston Area, East Coast, New England · Founded Date 2012 · Operating Status Active · Last Funding Type ...

Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the

This list of companies and startups in Greater Boston Area in the pharmaceutical space provides data on their funding history, investment activities, and.

Boston Pharmaceuticals - Crunchbase Company Profile & Funding Organization Boston Pharmaceuticals Connect to CRM Summary People Technology Signals & News About Boston Pharmaceuticals is a biotechnology company. Cambridge, Massachusetts, United States 11-50 Private www.bostonpharmaceuticals.com/ 142,137 Highlights Contacts 43 Employee Profiles 4

Legal Name Acetylon Pharmaceuticals, Inc. Company Type For Profit. Contact Email info@acetylon.com. Phone Number (617) 245-1300. Acetylon Pharmaceuticals, Inc. intends to manufacture small molecule drugs to realize the therapeutic potential of histone deacetylase. The company was incorporated in 2008 and is based in Boston, Massachusetts.

Boston Pharmaceuticals is a biotechnology company.

Cardurion is a Boston-based cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. In July, 2017, Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals announced the creation of a new preclinical partnership to develop novel, next-generation therapeutics for the

Industries. Biotechnology · Health Care · Medical · Pharmaceutical · Headquarters Regions Greater Boston Area, East Coast, New England · Founded Date 1987 ...

Pharmaceutical. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2011. Founders Ilyas Washington, Leonide Saad. Operating Status Active. Last Funding Type Grant. Company Type For Profit. Contact Email info@alkeus.com. Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic ...

Pharmaceutical. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2011. Founders Ilyas Washington, Leonide Saad. Operating Status Active. Last Funding Type Grant. Company Type For Profit. Contact Email info@alkeus.com. Alkeus Pharmaceuticals Inc., a Boston-based startup focused on treatments for serious ophthalmic ...

Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes. Boston, Massachusetts, United States ...

Juniper Pharmaceuticals (Nasdaq: JNP) is developing therapeutics that address unmet medical needs in women’s health. Their current pipeline leverages the 505(b)(2) regulatory pathway with new formulations of existing pharmaceuticals. The Company has a successful history in developing pharmaceutical products, including Crinone® 8% (progesterone

Boston Therapeutics - Crunchbase Company Profile & Funding Organization Boston Therapeutics Connect to CRM Summary Financials People Technology Signals & News About Boston Therapeutics develops and commercializes novel compounds for unmet medical needs in the areas of diabetes and inflammatory diseases. Lawrence, Massachusetts, United States 11-50

Overview · Recent News · Choose the right Crunchbase solution for you.

Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company

Boston Biomedical - Crunchbase Company Profile & Funding Organization Boston Biomedical Connect to CRM Summary Financials People Technology Signals & News About Boston Biomedical focuses on the research and development of novel therapeutics to treat cancer. Acquired by Dainippon Sumitomo Pharma Cambridge, Massachusetts, United States 51-100

Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2007. Founders Jeffrey V. Ravetch. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. Contact Email info@virdante.com. Phone Number 617-300-8500. Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and ...

Imbria Pharmaceuticals is a biotechnology company with locations in San Diego, CA, and Boston, MA.

Boston Pharmaceuticals acquires and transforms innovative molecules into differentiated medicines that improve patients’ lives. We have rapidly built a portfolio of high-value candidates across multiple therapeutic areas and are actively seeking additional programs for …